Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-25 of 25 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Tajikistan | Global Fund | Hetero labs Ltd. | Lamivudine | 10mg/ml oral solution 100ml | 1.2 | - | 1 | 1.2 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 2 | Ukraine | Government | Cipla Ltd | Lamivir | Lamivudine | 10mg/ml oral solution 100ml | 1.86 | 7896 | 1 | 1.86 | 7896 | 14686.56 | 2016 | Yes | Not specified | Yes | |||
| 3 | Republic of Armenia | Global Fund | Cipla Ltd | Lamivir | Lamivudine | 10mg/ml oral solution 100ml | 1.2 | 80 | 1 | 1.2 | 80 | 96 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Yes | ||
| 4 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Lamivudine | 10mg/ml oral solution 100ml | 2.2 | - | 1 | 2.2 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 5 | Ukraine | Government | Cipla Ltd | Lamivudine | 10mg/ml oral solution 100ml | 0.01 | 792596 | 1 | 0.01 | 792596 | 7925.96 | 2015 | Not specified | Not specified | Not specified | ||||
| 6 | Republic of Tajikistan | Global Fund | Cipla Ltd | Lamivudine | 10mg/ml oral solution 100ml | 1.2 | 4320 | 1 | 1.2 | 4320 | 5184 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 7 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Lamivir | Lamivudine | 10mg/ml oral solution 100ml | 2.2 | 1 | 1 | 2.2 | 1 | 2.2 | 2016 | No | Yes | Yes | |||
| 8 | Ukraine | Government | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 0.01 | 190000 | 1 | 0.01 | 190000 | 1900 | 2015 | Not specified | Not specified | Not specified | ||||
| 9 | Russian Federation | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 10.78 | 210 | 1 | 10.78 | 210 | 2263.8 | 2016 | Yes | Yes | Not specified | |||
| 10 | Republic of Belarus | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.5 | 432 | 1 | 1.5 | 432 | 648 | IDA Foundation | 2015 | 2015-12-22 | 2016-05-28 | Not specified | Not specified | Not specified | |
| 11 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Nevimun | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | 1 | 1 | 1.25 | 1 | 1.25 | 2016 | No | Yes | Yes | |||
| 12 | Republic of Belarus | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | 10008 | 1 | 1.25 | 10008 | 12510 | UNDP/UNICEF | 2016 | No | Yes | Not specified | |||
| 13 | Kyrgyz Republic | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 2.33 | 55 | 1 | 2.33 | 55 | 128.15 | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 14 | Republic of Tajikistan | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.3 | 1140 | 1 | 1.3 | 1140 | 1482 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 15 | Republic of Armenia | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | 84 | 1 | 1.25 | 84 | 105 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 16 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | - | 1 | 1.25 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 17 | Ukraine | Government | Cipla Ltd | Nevimun | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 2 | 1848 | 1 | 2 | 1848 | 3696 | 2016 | Yes | Yes | Yes | |||
| 18 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | - | 1 | 1.25 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 19 | Republic of Belarus | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.38 | 432 | 1 | 1.38 | 432 | 596.16 | UNDP/UNICEF | 2016 | No | Yes | Not specified | |||
| 20 | Kyrgyz Republic | Global Fund | Cipla Ltd | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 2.79 | - | 1 | 2.79 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 21 | Ukraine | Government | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 0.02 | 2310600 | 1 | 0.02 | 2310600 | 46212 | 2015 | Not specified | Not specified | Not specified | ||||
| 22 | Russian Federation | Government | ViiV Healthcare | Epivir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 18.57 | 793 | 1 | 18.57 | 793 | 14726.01 | 2016 | Yes | Yes | Not specified | |||
| 23 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 2 | 15 | 1 | 2 | 15 | 30 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 24 | Ukraine | Government | Aurobindo Pharma Ltd. | Zidovudine | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 5.03 | 9627 | 1 | 5.03 | 9627 | 48423.81 | 2016 | Yes | Not specified | Not specified | |||
| 25 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 2 | - | 1 | 2 | - | - | 2015 | Not specified | Not specified | Not specified |